Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Vaccinex's operating cash flow for the twelve months ending Dec 31, 2024 was -$16.19M. For fiscal 2024 it was -$16.19M. The highest annual figure on record is -$16.19M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$16.19M | – |
| FY2023 | Dec 31, 2023 | -$21.38M | – |
| FY2022 | Dec 31, 2022 | -$19.07M | – |
| FY2021 | Dec 31, 2021 | -$25.30M | – |
| FY2020 | Dec 31, 2020 | -$28.65M | – |
| FY2019 | Dec 31, 2019 | -$30.72M | – |
| FY2018 | Dec 31, 2018 | -$25.28M | – |
| FY2017 | Dec 31, 2017 | -$21.39M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$3.93M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.21M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.42M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.63M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.74M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.10M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.51M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.04M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.60M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.15M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.33M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.00M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.14M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.98M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.11M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.38M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.31M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.45M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.51M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.80M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.49M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.95M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.48M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.56M | – |
| Q3 FY2018 | Sep 30, 2018 | -$7.22M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.33M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.17M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.25M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.73M | – |
See a number that looks wrong?